551 results on '"Skibber, John"'
Search Results
152. Su1762 Primary Health Concerns Perceived By Long-Term Disease-Free Colorectal Cancer Survivors: A Qualitative Analysis
153. Mo1111 Completion of Follow-up After Abnormal Screening Test for Lynch Syndrome: A Framework for Multi-Level Cancer Care Delivery
154. How are colorectal cancer (CRC) patients treated following cancer recurrence during follow-up?
155. Is there an increase in elective utilization of non-operative management for rectal cancer?
156. A prospective evaluation of pelvic radiation vs. no radiation among patients with young-onset rectal cancer: Impact on patient-reported outcomes.
157. Do Survivors of Colorectal Cancer Need Continued Screening for Non-Colorectal Cancers?
158. A Prospective Six Sigma Quality Improvement Trial to Optimize Universal Screening for Genetic Syndrome Among Patients With Young-Onset Colorectal Cancer
159. Rectal Cancer, Version 2.2015
160. Impact of Recurrence and Salvage Surgery on Survival After Multidisciplinary Treatment of Rectal Cancer.
161. Comparative effectiveness of primary tumor resection in patients with stage IV colon cancer.
162. Palliative Therapy
163. Anal Cancer
164. Rectal Cancer
165. Colon, Rectal, and Anal Cancer Management
166. Risk-Adjusted Pathologic Margin Positivity Rate As a Quality Indicator in Rectal Cancer Surgery
167. Functional Deficits and Symptoms of Long-Term Survivors of Colorectal Cancer Treated by Multimodality Therapy Differ by Age at Diagnosis
168. Systemic Therapy for Advanced Appendiceal Adenocarcinoma: An Analysis From the NCCN Oncology Outcomes Database for Colorectal Cancer
169. Colon Cancer, Version 3.2014
170. Disparities in age-related incidence of colon and rectal cancer in the United States, 1975-2010.
171. 367 Persistent Functional Deficits and Symptoms Among Long-Term Survivors of Colorectal Cancer Treated With Surgery and Multimodality Therapy: Differences by Age at Initial Diagnosis
172. Neoadjuvant Radiotherapy Use in Locally Advanced Rectal Cancer at NCCN Member Institutions
173. Impact of Ileostomy-Related Complications on the Multidisciplinary Treatment of Rectal Cancer
174. Localized Colon Cancer, Version 3.2013
175. An Individualized Conditional Survival Calculator for Patients with Rectal Cancer
176. Population-based trends in positron emission tomography (PET) utilization after resection for colon cancer.
177. Comparative Analysis of Lymph Node Metastases in Patients With ypT0-2 Rectal Cancers After Neoadjuvant Chemoradiotherapy
178. Metastatic Colon Cancer, Version 3.2013
179. Metformin use and improved response to therapy in rectal cancer
180. Postoperative Adjuvant Chemotherapy Use in Patients With Stage II/III Rectal Cancer Treated With Neoadjuvant Therapy: A National Comprehensive Cancer Network Analysis
181. Multimodality Salvage of Recurrent Disease After Local Excision for Rectal Cancer
182. Rectal Cancer
183. The association between psychosocial and medical factors with long-term sexual dysfunction after treatment for colorectal cancer
184. Morbidity of Staged Proctectomy After Hepatectomy for Colorectal Cancer: A Matched Case–Control Analysis
185. Exploratory analysis of adjuvant chemotherapy benefits after preoperative chemoradiotherapy and radical resection for rectal cancer.
186. Neoadjuvant Treatment Response As an Early Response Indicator for Patients With Rectal Cancer
187. Sa1117 Toward Universal Testing for Hereditary Nonpolyposis Colorectal Cancer (HNPCC) Syndrome in Young Patients With Colorectal Cancer: A Quality Improvement Initiative
188. Anal Carcinoma, Version 2.2012
189. Pretreatment High-Resolution Rectal MRI and Treatment Response to Neoadjuvant Chemoradiation
190. MR Imaging for Preoperative Evaluation of Primary Rectal Cancer: Practical Considerations
191. Lymph node metastasis in patients with early pathologic T-stage rectal cancers: What does local excision leave behind?
192. Exploratory analysis of adjuvant chemotherapy effects after preoperative chemoradiotherapy and radical resection for rectal cancer.
193. Intensity-modulated radiation therapy (IMRT) with concurrent chemotherapy for anal cancer: A large single-institution experience.
194. Detection of hereditary nonpolyposis colorectal cancer (HNPCC) in non-Caucasian patients.
195. Morbidity of staged proctectomy after hepatectomy for colorectal cancer: A matched case-control analysis.
196. Reverse-Hybrid Robotic Mesorectal Excision for Rectal Cancer
197. What determines adjuvant chemotherapy use after neoadjuvant chemoradiotherapy for rectal cancer?
198. Preoperative radiation therapy with concurrent capecitabine, bevacizumab, and erlotinib for rectal adenocarcinoma: A phase I trial.
199. Systemic therapy for advanced appendiceal adenocarcinoma: An analysis from the National Comprehensive Cancer Network (NCCN) database.
200. Detecting hereditary nonpolyposis colorectal cancer syndrome (HNPCC) in patients with colorectal cancer (CRC): Optimal strategies at lower costs.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.